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Background: The leaves of Cupressus lusitanica Mill. are used in the western highlands of Cameroon for their
medicinal property.
Methods: The leaves of this species were collected in the West Region of Cameroon in August 2010 and subjected
to hydrodistillation to obtain the essential oil. The oil was fractionated using adsorption column chromatography.
The chemical composition of this oil and its fractions was analysed by gas chromatography–mass spectrometry
(GC-MS). The essential oil and fractions were tested for antimicrobial activity against eight bacterial species and six
species of Candida by the agar diffusion method. Macrodilution method was used to determine the minimum
inhibition concentrations (MICs) and minimum bactericidal and/or fungicidal concentrations (MBCs and MFCs). The
toxicity profile of the oil was studied using Swiss mice and Wistar albino rats.
Results: Forty-nine compounds were identified in the essential oil. The main components were germacrene D
(18.5%), epi-zonarene (8.2%), cis-calamenene (8.2%), terpinen-4-ol (6.3%), linalool (6.0%) and umbellulone (6.0%).
Enterococcus faecalis, Proteus mirabilis and Candida albicans were most susceptible to the oil (MICs of 1.25 and
0.16% for bacteria and fungi respectively). The estimated oral LD50 was 6.33 g/kg. There was an increase in sera ALT
and AST activities while the blood cells and protein levels decreased in treated animals.
Conclusion: The results obtained from this study support the ethnomedicinal use of C. lusitanica leaf oil in the
treatment of whooping cough and skin infections though it should be used with care. This plant oil could be
useful in the standardisation of phytomedicine.
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Down the ages, essential oils and other extracts of plants
have evoked interest as sources of natural products.
They have been screened for their potential uses as alter-
native remedies for the treatment of many infectious di-
seases [1] since the spread of drug resistant pathogens is
becoming a serious threat to successful treatment of
microbial diseases. Phytotherapy includes the usage of
medicinal and aromatic plants, which constitute a major
source of natural organic compounds, to alleviate illnesses.
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reproduction in any medium, provided the orantifungal, antiviral insecticidal and antioxidant properties
[2,3] and anticancer activity [4]. There has been an in-
creased interest in looking at antimicrobial properties of
extracts from aromatic plants particularly essential oils
[5]. Therefore, it is reasonable to expect a variety of plant
compounds in these oils with specific as well as general
antimicrobial activity and antibiotic potential [6].
These natural compounds are complex and volatile
products formed by aromatic plants as secondary meta-
bolites [7]. They are known for their bactericidal, virucidal,
fungicidal, sedative, anti-inflammatory, analgesic, spasmo-
lytic, and local anesthetic properties [7]. Chemically, these
volatile products and their oxygenated compounds are de-
rived from terpenes [8]. Each of these constituents con-
tributes to the beneficial or adverse effects.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ring plant, is a tree attaining 25–30 m in height. It was
introduced in Cameroon during the colonial era and
today is mainly found in the western highlands [9]. The
essential oil from the leaves of C. lusitanica is commonly
used to treat haemorrhoids, rheumatism, whooping cough
and styptic problems [10]. The leaves of C. lusitanica are
used traditionally to protect stored grains from insect in-
festation and also to cure skin diseases.
It has also been demonstrated that C. lusitanica oil
has an inhibitory effect against dermatophytes [11]. The
essential oil of three samples of C. lusitanica from
Portugal has been found to be rich in α-pinene, sabinene
and abietadiene [12]. In related studies, Floreani et al.
[13] reported α-pinene and δ-3-carene as major constit-
uents while Carmo and Frazao [14] revealed that myr-
cene, sabinene, α-pinene, β-pinene, δ-3-carene were the
main constituents. To the best of our knowledge, no sci-
entific work was seen reporting on the toxicity profile of
the Cameroonian Cupressus lusitanica leaf essential oil.
In the present study, the chemical composition, anti-
microbial properties and possible deleterious effects of the
essential oil from C. lusitanica leaves were investigated.
Methods
Plant material and extraction of essential oil
Fresh leaves were collected from non-flowering Cupres-
sus lusitanica Mill. plants in the campus of the Uni-
versity of Dschang in August 2010. The plant material
was identified at the Cameroon National Herbarium in
Yaounde where a voucher specimen is deposited under
the code number HNC 66102. The leaves were subjected
to hydrodistillation in batches of 2 kg in 3 L of water
using a Clevenger-type apparatus. The obtained essential
oil was dried over anhydrous sodium sulphate and stored
at + 4°C until tested and analyzed.
Fractionation of essential oil
Five grams of the essential oil was subjected to column
chromatography on silica gel (20 g, silica gel 40G, co-
lumn 30 × 300 mm) with a gradient of hexane-acetyl
acetate (95:5, 90:10, 85:15, 80:20, 70:30, 50:50, 25:75),
100% acetyl acetate and methanol. 80 fractions were col-
lected. The band patterns of the fractions were examined
on silica gel plates (silice 60G, type F254, Alugram® SIL)
with hexane-acetyl acetate (8:2 v/v) as the developing re-
agent. The plates were sprayed with 50% of sulphuric
acid and heated at 100°C for band visualization. Frac-
tions showing similar band patterns were combined and
a total of seven fractions (F1-F7) were obtained.
GC-MS analysis conditions
The GC/MS analysis of the essential oil was performed
using a Hewett-Packard 5890II GC, equipped with aHP-5 MS capillary spectrometer (30 m × 0.25 mm i.d.,
0.25 μm film thickness) and a mass system with ioni-
zation energy of 70 ev. Helium was the carrier gas at a
flow rate of 1 ml/min. Injector and MS transfer line tem-
peratures were set at 220 and 290°C, respectively. Co-
lumn temperature was gradually increased from 50 to
150°C at a rate of 3°C/min, and then held for 10 min.
Finally, it was raised to 250°C at 10°C/min. Diluted
samples (1:100 v/v in hexane) of 1.0 μl were injected
manually in the split-less mode. The components were
identified by comparing their relative retention times
and mass spectra with those of standards, NBS75K li-
brary data of the GC/MS system, and literature data
[15]. The results were further confirmed by comparing
the elution order of the compounds with their relative
retention indices on non-polar phases as reported by
Adams [15].
Microorganisms and growth conditions
The microorganisms used in this study consisted of two
Gram (+) bacteria- Enterococcus faecalis ATCC 10541
and Staphylococcus aureus ATCC 25922; six Gram (−)
bacteria- Escherichia coli ATCC 11775, Klebsiella pneu-
moniae ATCC13883, Proteus mirabilis, Pseudomonas
aeruginosa ATCC 27853, Salmonella typhi ATCC 6539
and Shigella flexneri; and 6 fungi- Candida albicans
ATCC 9002, C. glabrata IP 35, C. krusei ATCC 6258, C.
lusitaniae ATCC 200950, C. parapsilosis ATCC 22019
and C. tropicalis ATCC 750. The reference strains (ATCC)
were obtained from American Type Culture Collection.
The two clinical bacterial isolates were collected from
Pasteur Center (Yaounde-Cameroon) and the candidal
strain was obtained from Pasteur institute (IP, Paris-
France). The bacterial and candidal strains were grown
at 35°C and maintained on nutrient agar (NA, Conda,
Madrid, Spain) and Sabouraud Dextrose Agar (SDA,
Conda) slants respectively.
Antimicrobial assay
The essential oil and its fractions from C. lusitanica
were tested for antimicrobial activities using agar disc
diffusion technique to determine the diameter of growth
inhibition zones while broth macrodilution method was
used to determine the MIC and MBC/MFC.
Agar diffusion test
The disc diffusion method [16] was employed for the
determination of antimicrobial activities of essential oil
and its fractions (F1, F3, F4 and F5). Briefly, 0.1 ml
of suspension of the test microorganisms containing
1.5 × 107 cfu/ml of bacteria or 1.5 × 106 spores/ml was
spread on Mueller Hinton agar or Sabouraud dextrose
agar medium respectively. Filter paper discs (Whattmann
n°3, 6 mm in diameter) were soaked with 10 μl of the
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fractions (10%, 1%, 0.1%v/v), and placed on the seeded
plates. A negative control was prepared using the solvent
(10% DMSO) employed to dissolve the oil. Gentamicin
and nystatin (10 μg/disc) were used as positive reference
drugs for bacteria and fungi respectively. The fractions F2,
F6 and F7 were not tested in this assay due to insufficient
quantities. The plates were incubated at 37°C (24 hrs) for
bacterial strains, and 35°C (48 hrs) for yeast. Antimicrobial
activity was evaluated by measuring the diameters of in-
hibition zones. Each assay in this experiment was repeated
three times.
Broth macrodilution tests
The minimal inhibitory concentration values were deter-
mined for all bacterial and candidal strains using the
macrowell dilution method as described by Zgoda and
Porter [17]. The inocula of the bacterial and fungal
strains were cultured 18 hrs at 37°C in nutrient broth
(NB) and 48 hrs at 35°C in Sabouraud dextrose broth
(SDB) respectively. Tests strains were suspended in ster-
ile saline to give a final density of 1.5 × 106 cfu/ml of
bacteria or 1.5 × 105 spores/ml.
The 24 well plates were prepared by dispensing into
each well 500 μl of nutrient broth. A 500 μl of C.
lusitanica essential oil initially prepared at the concen-
tration of 40% v/v was added into each of the first wells,
followed by 2-fold serial dilution to obtain concentration
range of 10 to 0.08% v/v. To this was separately added
500 μl of the prepared inoculum. The last well con-
taining 500 μl of nutrient broth/Sabouraud dextrose
broth without test substance and 500 μl of the inoculum
on each strip was used as the negative control. The final
volume in each well was 1 ml. The final concentration of
Tween 80 in each medium was 0.5%, which did not
affect the growth of the tests microorganisms. Gentami-
cin and nystatin at concentrations ranging respectively
from 250–15 μg/ml, and 16–2 μg/ml were used as posi-
tive controls. Culture medium + Tween 80 + test oil was
used as the sterility control. The fractions F2, F6 and F7
were not tested in this assay due to insufficient quan-
tities. The plates were covered with a sterile plate sealer
and incubated under normal atmospheric pressure at
37°C (24 hrs) for bacterial strains, and 35°C (48 hrs) for
yeast. The test samples were screened three times
against each microorganism. The bacterial or fungal
growth was indicated by the presence of turbidity and/or
a white “pellet” at the bottom of the well. The minimum
inhibitory concentration was determined as the lowest
concentration of the test compound that demonstrated
no visible growth. The minimum bactericidal/fungicidal
concentration (MBC/MFC) was determined by making
subcultures of 10 μl of each well showing no turbi-
dity, and negative control on nutrient agar or sabourauddextrose agar. Subcultures of bacteria and fungi were in-
cubated at 37°C (24 hrs) and 35°C (48 hrs) respectively.
The MBC or MFC was considered as the lowest concen-
tration of oil resulting in no growth (death) of the sub-
cultured inoculum compared to the negative control [18].
Animals used
Male Wistar albino rats (110–120 g) and Swiss mice
(22–25 g) were used for the toxicity assay. They were
housed in standard plastic cages and provided with food
and water ad libitum. The studies were conducted ac-
cording to the ethical guidelines of the Committee for
Control and Supervision of Experiments on Animals
(Registration no. 173/CPCSEA, dated 28 January, 2000),
Government of India, on the use of animals for scientific
research.
Acute toxicity assay
This study was carried out in mice (males) as descri-
bed by Emerson et al. [19]. Swiss albino mice of age
7–8 weeks were chosen at random and assigned to 5 dif-
ferent groups of 6 mice each (3 per cage). Food and
water were withdrawn 18 hrs before the oral administra-
tion of 0.8 ml oil solution to the mice at the doses 2 to
8 g/kg of bodyweight (with a constant increment of 2).
The fractions were not tested in this assay due to insuffi-
cient quantities. The control animals received 0.8 ml so-
lution of 8% DMSO. The animals were observed for
mortality and behavioural responses for 48 hrs, after
which the number of deaths in each group was noted.
The effect of the oil was assessed on the basis of morta-
lity, expressed as median lethal dose (LD50). The LD50
value of the essential oil solution was evaluated by calcu-
lation [20].
Subacute toxicity assay
For this assay, 30 Wistar rats (males) aged 8 weeks were
used. They were chosen at random and assigned to 5
different groups of 6 rats each (2 per cage). The control
group received 0.5 ml of 8% DMSO solution while the
test groups received corresponding doses of essential oil
solution (from 0.8 to 2 g/kg with an increment of 0.4).
All the animals were orally gavaged daily for four weeks
and were observed for physiological, behavioural res-
ponses and for mortality.
Twenty-four hours after the last administration, the
rats were anaesthetized and blood collected by cardiac
puncture into heparinised and non-heparinised centri-
fuge tubes to evaluate some biochemical parameters and
estimate blood cells. The heparinised blood was used to
verify total red blood cell and white blood cell counts
[21], and heamatocrit level [22]. Serum was prepared
from non-heparinised blood and assessed for alanine ami-
notransferase (ALT), asparatate aminotransferase (AST),
Table 1 Chemical compounds (%) and retention indices (RI) of C. lusitanica Mill. leaf oil and its fractions
Compounds RIa %
EOb F1 F2 F3 F4 F5 F6 F7
1 tricyclene 923 0.3 - - - - - - -
2 α-pinene 936 0.6 0.3 - 5.4 - - 0.6 2.5
3 sabinene 973 0.3 - - 0.5 - - - -
4 myrcene 987 0.4 0.3 - - - - - -
5 δ-3-carene 1001 0.5 0.7 - 1.5 0.3 - - -
6 α-phellandrene 1003 0.1 - - - - - - -
7 α-terpinene 1014 0.2 - - 5.4 - - - -
8 p-cymene 1017 0.5 0.9 5.5 1.9 - - - -
9 limonene 1021 2.3 1.6 - 1.0 - - 1.9 1.4
10 1,8-cineole 1022 0.8 - - 0.5 0.1 - - -
11 γ-terpinene 1057 0.4 - - 6.8 0.3 - 5.1 -
12 cis-linalooloxide 1067 0.5 - - - - 1.2 - -
13 α -terpinolene 1083 - 0.3 - - - - - -
14 linalool 1095 6.0 - - 0.5 6.4 - - -
15 umbellulone 1164 6.0 - - 2.8 5.9 - 3.6 -
16 terpinen-4-ol 1171 6.3 - - 1.6 26.3 - 2.7 -
17 p-cymen-8-ol 1178 1.0 0.2 - - - - 2.1 1.4
18 p-menth-2-en-1-ol 1213 0.3 - - - 10.5 - - -
19 citronellol 1229 0.2 - - - - - - -
20 linalyl acétate 1250 1.2 - - 11.3 - - 4.3 -
21 thymol 1254 0.4 - - 2.7 0.6 - - -
22 α -cubebene 1346 0.3 - - 10.0 - 4.7 3.1 -
23 α-copaene 1373 0.1 0.5 - 3.5 - - - -
24 α-cedrene 1403 0.1 0.3 - - 9.5 - - -
25 β-caryophyllene 1411 1.5 - - - - - - -
26 β-cedrene 1413 0.4 9.1 - - - - - -
27 α-humulene 1448 0.6 0.9 - - - - - -
28 zingiberene 1472 0.1 0.3 - - - - - -
29 α-curcumene 1478 4.1 11.6 5.3 22.6 - - 3.6 7.3
30 germacrene D 1481 18.5 - - - 1.9 - - 13.9
31 α-amorphene 1482 2.0 6.9 - - - - - -
32 epi-zonarene 1498 8.2 - - - - 4.7 3.1 -
33 α-muurolene 1501 1.1 1.9 - - - - - -
34 cuparene 1503 - 1.7 - - - - - -
35 β-bisabolene 1504 0.3 1.8 - - - - - -
36 α-cadinene 1510 0.2 - - - 0.6 - - -
37 γ-cadinene 1511 - - - - 2.0 - - -
38 cis-calamenene 1521 8.2 20.1 - - - - - -
39 α-calacorene 1530 0.5 0.4 - - - - - -
40 spathulenol 1576 0.2 - 2.8 - - - - -
41 caryophyllene oxide 1584 0.6 0.6 - 10.4 - - 3.6 -
42 cedrol 1591 1.2 - - - 17.2 7.6 - -
43 di-epi-α-cedrene 1633 4.9 1.2 - - - 14.8 - -
Teke et al. BMC Complementary and Alternative Medicine 2013, 13:130 Page 4 of 9
http://www.biomedcentral.com/1472-6882/13/130
Table 1 Chemical compounds (%) and retention indices (RI) of C. lusitanica Mill. leaf oil and its fractions (Continued)
44 14-norcadin-5-en-4-one 1696 0.9 4.5 32.0 - - - 6.3 4.3
45 trans-nuciferol 1718 - - 4.9 - - - - -
46 naphthalene 1780 0.8 0.4 17.6 - 4.3 3.2 3.6 5.2
47 kaur-15-ene 1974 0.2 0.4 - - - - - -
48 cis-totarol 2277 - - - 1.6 0.2 - - -
49 ferruginol 2324 - - - 0.5 - - - -
Monoterpene hydrocarbons 5.6 4.1 5.5 22.5 0.6 - 7.6 3.9
Oxygenated monoterpenes 22.7 0.2 - 19.4 49.8 1.2 12.7 1.4
Sesquiterpene hydrocarbons 51.9 57.1 22.9 36.1 18.3 27.4 13.4 26.4
Oxygenated sesquiterpenes 2.9 5.1 39.7 10.4 17.2 7.6 9.9 4.3
Others 0.2 0.4 - 2.1 0.2 - - -
Total identified 83.3 66.9 68.1 90.5 86.1 36.2 43.6 36.0
a Compounds are listed in order of their elution from an HP-5 column using the homologous series of n-alkanes; bEssential oil (EO), fractions F1 to F7;
- Not detected.
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commercial kits (BioSystems reagents and instruments).
Protein levels in sera and organ homogenates were eval-
uated by the Biuret’s method [23].
Statistical analysis
The data were subjected to one-way analysis of variance,
and differences between samples at P ≤ 0.05 were deter-
mined by Student-Newmann-Keuls multiple range test
using the Statistical Package for the Social Sciences
(SPSS) program. Experimental results were expressed
(where appropriate) as mean ± SEM (standard error to
the mean).
Results
Chemical composition of essential oil and its fractions
GC/MS analysis of the crude oil (yield of 0.32%) resul-
ted in the identification of 49 compounds representing
83.3%. Germacrene D (18.5%) epi-zonarene (8.2%), cis-
calamenene (8.2%), terpinen-4-ol (6.3%), linalool (6.0%)
and umbellulone (6.0%) were the main components, com-
prising 53.2% of the oil (Table 1). Fractions F1 and F3
were rich in composition than the other fractions.
Antimicrobial activities
The crude essential oil of C. lusitanica showed anti-
microbial activities against all the bacteria and fungi
tested. The highest activity was observed on bacteria.
The diameters of inhibition zones for bacterial and fungal
strains were in the ranges of 11–18 mm and 7–14 mm re-
spectively (Table 2). This activity was highest at 10% v/v of
oil and was observed to decrease with concentration. The
fractions of this oil were less active and selective com-
pared to the crude oil. These fractions inhibited most the
growth of bacteria with diameter of inhibition zones var-
ying from 7–10 mm.The MICs and MBCs/MFCs for the crude oil (quantity
of fractions was not enough for the assay) are given in
Table 3. Generally, all the microorganisms were sensitive
to the test sample. The MIC values of oil for bacteria
ranged from 1.25- 10% v/v, with E. faecalis and P.
mirabilis being the most sensitive while P. aeruginosa
was the least sensitive. It was observed that the fungal
strains were more susceptible to the leave essential oil
(MIC range from 0.16-1.25% v/v) than bacteria. C.
albicans was the most sensitive fungal strain.
Effects of single oral dose of essential oil on mice
The acute toxicity study of C. lusitanica leaf oil on mice
showed a slight tolerance to the oil solution. For doses ≥
4 g/kg the animals responded in uncontrolled move-
ments; their respiratory rhythm increased progressively
with increase in dose. The oil provoked deaths of mice;
2 g/kg (0/6), 4 g/kg (1/6), 6 g/kg (2/6) and 8 g/kg
(6/6), within 48 hours observation period. The lethal
dose-50 (LD50) of this extract was evaluated as 6.33 g/kg
bodyweight.
Subacute toxicity
After subjecting the rats to a daily treatment of C.
lusitanica leaf oil for four weeks, the animals expressed
some changes in their behavioural profile in the test
groups. Decreases in movement, aggressiveness, response
to touch and noise, and respiratory rhythm were observed.
No death was recorded during this treatment either in the
control or in the drug-treated groups.
From haematological and biochemical observations
(Table 4), the red blood cells and white blood cells de-
creased with increase in dose of oil. This decrease was
significant at 1.5 and 2 g/kg with respect to the control.
In a like manner, the heamatocrit levels also decreased
with the rising doses of oil, and were significantly higher
Table 3 Minimal inhibitory concentration (MIC)/Minimum bactericidal or fungicidal concentration (MBC or MFC) of test
substances
Microoganisms MIC MBC/MFC
Gram (−) bacteria Essential oil (%) Reference (μg/ml) Essential oil (%) Referencea (μg/ml)
Escherichia coli ATCC 11775 2.5 31.25 2.5 31.25
Klebsiella pneumoniae ATCC 13883 5.00 31.25 >10.00 31.25
Proteus mirabilis 1.25 125 1.25 250
Pseudomonas aeruginosa ATCC 27853 10.00 31.25 >10.00 31.25
Salmonella typhi ATCC 6539 2.5 62.50 2.5 125
Shigella flexneri 2.5 62.50 2.5 125
Gram (+) bacteria
Enterococcus faecalis ATCC 10541 1.25 15.62 2.5 15.62
Staphylococcus aureus ATCC 25922 1.25 62.50 2.5 62.50
Fungi
Candida albicans ATCC 9002 0.16 2 0.16 2
Candida glabrata CIPA 35 1.25 16 1.25 16
Candida krusei ATCC 6258 1.25 4 1.25 4
Candida lusitaniae ATCC 200950 0.62 2 0.62 >2
Candida parapsilosis ATCC 22019 1.25 16 1.25 16
Candida tropicalis ATCC 750 1.25 8 1.25 8
The results are the mean values of triplicate tests measured after 24 hrs (at 37°C for bacteria) and 48 hrs (at 35°C for fungi) incubation; a Reference compounds
were gentamicin and nystatine for bacteria and fungi respectively.
Table 2 Mean diametersa of microbial growth inhibition zones (mm) of test samplesb
Microoganisms Samples
EO F1 F3 F4 F5 Referencec
Gram (−) bacteria 100% 10% 1% 10% 1% 0.1% 10% 1% 0.1% 10% 1% 0.1% 10% 1% 0.1% 10 μg
Escherichia coli ATCC 11775 12 9 6 6 6 6 9 8 6 8 8 7 9 7 7 21
Klebsiella pneumoniae ATCC 13883 11 8 6 8 7 6 8 6 6 9 8 7 8 6 6 20
Proteus mirabilis 11 9 6 13 12 11 8 8 6 12 11 10 12 10 9 18
Pseudomonas aeruginosa ATCC 27853 13 9 6 9 7 6 9 7 6 7 6 6 7 6 6 24
Salmonella typhi ATCC 6539 11 9 6 8 8 6 8 7 6 7 7 6 6 6 6 24
Shigella flexneri 18 13 8 12 8 6 10 8 6 9 7 6 8 7 6 23
Gram (+) bacteria
Enterococcus faecalis ATCC 10541 16 12 6 12 10 9 10 8 6 10 8 8 13 11 10 20
Staphylococcus aureus ATCC 25922 16 11 7 10 8 6 11 8 6 9 7 6 8 7 6 25
Fungi
Candida albicans ATCC 9002 13 7 6 6 6 6 6 6 6 6 6 6 6 6 6 22
Candida glabrata CIPA 35 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 23
Candida krusei ATCC 6258 10 6 6 6 6 6 6 6 6 6 6 6 6 6 6 18
Candida lusitaniae ATCC 200950 13 10 6 12 9 9 11 9 7 12 10 6 14 12 10 33
Candida parapsilosis ATCC 22019 7 6 6 6 6 6 6 6 6 6 6 6 6 6 6 24
Candida tropicalis ATCC 750 14 7 6 6 6 6 6 6 6 6 6 6 7 6 6 23
The results are the mean values of triplicate tests measured after 24 hrs (at 37°C for bacteria) and 48 hrs (at 35°C for fungi) incubation; aDiameter value of 6 mm is
equal to disc diameter, implying no activity; bEssential oil (EO), fractions of essential oil (F1, F3, F4 and F5); cReference compounds were gentamicin and nystatine
for bacteria and fungi respectively.
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Table 4 Effects of essential oil of C. lusitanica on some biochemical parameters in rats
Biochemical parameters




Hematocrit (%) ALTa (U/l) AST (U/l) ALP (U/l) Creatinine
(mg/l)
Control 0 8052 ± 451 6456 ±1690 45.78 ±1.61 10.11 ± 2.32 6.63 ± 0.34 14.12 ± 2.17 24.75 ± 1.68
Essential oil of
C. lusitanica
0.8 7066 ± 326 6700 ± 689 43.33 ± 1.83 13.46 ± 3.45 9.59 ± 3.10 14.19 ± 0.99 17.50 ± 2.31*
1.2 6908 ± 265* 5657 ± 427 42.14 ±1.39* 15.70 ± 3.17* 16.65 ± 2.27* 12.06 ± 4.52 14.40 ± 3.20*
1.6 6482 ± 279* 5640 ± 203 38.73 ±1.17* 17.44 ± 3.61* 30.00 ± 3.59* 10.86 ± 0.00* 11.40 ± 3.20*
2 6018 ± 567* 3133 ± 689* 35.96 ± 1.05* 19.79 ± 3.14* 32.65 ± 3.61* 11.76 ± 0.99* 11.00 ± 3.17*
Values are means ± SE of six animals. For the same column, values affected by * are significantly different form the control (test of Student-Newmann-Keuls at p >
0.05); aalanine aminotransferase (ALT), asparatate aminotransferase (AST), Alkaline phosphatase (ALP).
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test doses (Table 4). The least level (35.96 ± 1.05%) of
heamatocrit was recorded at 2 g/kg dose of oil.
In the study of the effects of C. lusitanica leaf oil on
some serum enzymes, it was observed that the oil pro-
voked a significant increase in transaminase (AST and
ALT) levels in serum at doses of 1.2, 1.6 and 2 g/kg.
Compared to the control values of AST (6.63 ± 0.34 U/l)
and ALT (10.11 ± 2.32 U/l), the dose of 2 g/kg of oil
provoked the greatest increase of 32.65 ± 3.61 U/l and
19.79 ± 3.14 U/l levels of the respective enzymes.
The activity of alkaline phosphatase (ALP) in the
serum was not significantly different (P ≤ 0.05) from the
control after the oil treatment at the tested doses
(Table 4). The creatinine level in serum decreased pro-
gressively with increase in essential oil dose (Table 4).
The least value (11.00 ± 3.17 mg/l) observed at 2 g/kg
was significantly different from the control (24.75 ±
1.68 mg/l).
The protein levels in the studied organs and serum
decreased as the oil dose increased. This decrease was
significant for the liver, heart, lungs, kidneys, spleen
and serum at the dose 2 g/kg compared to the control
(Table 5). The heart (71.66 ± 11.43 mg/g) and kidneys
(117.20 ± 5.24 mg/g) were most affected since at 0.8 g/kg
(least test dose) these values were significantly lower than
the control (81.96 ± 17.32 mg/g and 156.37 ± 4.65 mg/g
respectively).Table 5 Effects of essential oil of C. lusitanica treatment on ti
Treatment Dose Liver Heart
(g/kg) (mg/g) (mg/g)
Control 0 81.96 ± 17.32 119.83 ± 6.97
Essential oil of C. lusitanica 0.8 71.66 ± 11.43 110.73 ± 11.56
1.2 63.13 ± 5.55* 102.17 ± 9.92
1.6 58.98 ± 4.38* 104.27 ± 5.79
2 52.65 ± 9.57* 79.43 ± 4.73*
Values are means ± SE of six animals. For the same column, values affected by * are
at p > 0.05).Discussion
The traditional use of plants as medicines provide the
basis for indicating which essential oils and plant oils
may be useful for specific medical conditions. Histo-
rically, many plant oils and extracts, have been used as
topical antiseptics, or have been reported to have anti-
microbial properties [24]. It is important to investigate
scientifically those plants which have been used in tra-
ditional medicines as potential sources of novel anti-
microbial compounds. Also, the resurgence of interest in
natural therapies and increasing consumer demand for
effective, safe and natural products means that quantita-
tive data on plant oils and extracts are required. This
study was aimed to characterize chemically and evaluate
the antimicrobial activity and toxicity profile of C. lusi-
tanica leaf essential oil.
The results on chemical characterization of the essen-
tial oils from C. lusitanica obtained by GC-MS analyses
revealed the predominance of germacrene D, epi-zona-
rene, cis-calamenene, terpinen-4-ol, linalool and umbel-
lulone. This finding is slightly different with the previous
reports of Adams et al. [12] and Kuiate et al. [11]. The
former authors noted that α-pinene, sabinene and um-
bellulone were the major components in the essential oil
from the leaves of C. lusitanica samples from Portugal,
while the latter remarked the presence of α-pinene, um-
bellulone, germacrene D and epi-zonarene as the main
components. This difference in composition between thessue protein levels in rats
Tissues
Lungs Kidneys Spleen Serum
(mg/g) (mg/g) (mg/g) (g/l)
168.91 ± 5.62 156.37 ± 4.65 123.93 ± 13.73 21.16 ± 0.73
153.86 ± 5.28 117.20 ± 5.24* 123.61 ± 18.41 18.73 ± 1.75
123.03 ± 3.35* 112.95 ± 3.78* 110.93 ± 12.16 17.58 ± 0.58
102.01 ± 4.98* 82.71 ± 4.26* 116.42 ± 20.14 10.24 ± 1.13*
100.01 ± 4.25* 31.10 ± 6.16* 61.43 ± 11.67* 9.24 ± 0.50*
significantly different form the control (test of Student-Newmann-Keuls
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matic, seasonal factors and harvest areas [25].
The results of the antimicrobial activities showed that,
the essential oil of C. lusitanica leaves had moderate
antimicrobial activities against all the microorganisms
(8 bacteria and 6 Candida). This oil showed a greater
antibacterial activity compared to antifungal activity with
the standard method of disc diffusion. Contrary, can-
didal species were more sensitive in the macrodilution
method. The higher activity of essential oil with the
macrodilution compared to disc diffusion method may
be due to growth conditions [26]. The antimicrobial na-
ture of the essential oil may be attributed to the pres-
ence of β-myrcene, limonene, phellandrene, γ-terpinene,
caryophyllene and thymol among the constituents [27-29].
The essential oils containing terpenes are also reported to
possess antimicrobial activity [30], which are consistent
with our present study. In addition, the components in
lower amounts may have also contributed to the anti-
microbial activity of the essential oils, involving probably
some type of synergism with other active compounds [31].
This could explain why the antibacterial activities of the
fractions decreased with respect to the crude essential oil.
These differences in antimicrobial activities could be
linked to their differential chemical compositions. In the
present study, the essential oil from C. lusitanica leaves
was found to be equally effective against both gram-
positive and gram-negative organisms though the Gram-
positive bacteria were more resistant to the essential oils
than gram-negative bacteria [32]. The differences between
MIC and MBC or MFC values were not more than 2-fold,
suggesting that the activity of essential oil of this plant
could be bactericidal and fungicidal [33]. It is worth men-
tioning that the antimicrobial activity of the essential oil
from C. lusitanica leaves from Cameroon is herein repor-
ted for the first time.
An important characteristic of essential oils and their
components is their hydrophobicity, which enable them
to partition the lipids of the bacterial cell membrane and
mitochondria, disturbing the cell structures and ren-
dering them more permeable [34,35]. Extensive leakage
from bacterial cells or the exit of critical molecules and
ions will lead to death [36].
The antimicrobial activity of this plant prompted us to
evaluate to what extent the oil could provoke deleterious
effects. With a lethal dose-50 (LD50) of 6.33 g/kg, the es-
sential oil of C. lusitanica leaves can be considered less
toxic [37]. The decrease in movement, aggressiveness,
sensitivity to touch and noise may result from the action
of this oil on the central nervous system [38,39]. It was
suggested that the death of mice may be related to res-
piratory failure due to poor ventilation of the lungs. This
idea was put forward due to the fact that the breathing
rhythm of some of these animals was abnormal as itincreased progressively with time after the administration
of essential oil. Some of the mice were observed res-
ponding as if they were suffocating and/or having diffi-
culty in breathing. This is in corroboration to the findings
of Joseph et al. [40].
Transaminases (ALT and AST) are concerned with
amino acids metabolism. Large amount of AST are pre-
sent in the liver, kidneys, cardiac and skeletal muscles,
while ALT is found principally in the liver [41]. Small
amount of AST are present in the brain, pancreas, and
lungs. The serum or plasma levels of both AST and ALT
rise whenever there is liver cell damage. The higher ac-
tivities of both enzymes reflect the greater degree of liver
damage [42,43]. An increased serum activity of these en-
zymes in the present study indicates that the extract
may have significant cytotoxic effects on the liver. The
extract could affect the permeability of the cell mem-
brane causing the membrane to become leaky. This
would then induce the release of these enzymes from
the cells into the blood stream, thereby causing the sub-
sequent plasma or serum elevation of the enzymes [44].
The reduction of blood cells observed in the treated
animals could be ascribed to oil toxicity linked to bone
marrow failure [45] or liver and spleen affection [21].
Rats that received the oil at high doses exhibited de-
creases in serum total proteins concentration and total
protein concentration of the liver on the other studied
organs, suggesting tissue injury [19]. The drop in organ
and blood protein levels could cause metabolic and phy-
siological variations, susceptible to provoke disequilibria
and behavioural problems observed in the rats. The
study of possible toxic effects of C. lusitanica leaf essen-
tial oil is herein being reported for the first time.
Conclusion
The results of this work show that the C. lusitanica
essential oil, rich in aromatic compounds, possesses an-
timicrobial properties, which can be used as a natural
antimicrobial agent for human infectious diseases. This
oil may exert deleterious effects at high doses. Further
studies are necessary to elucidate the mechanism of ac-
tion of this oil.
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